The Nature of Immunity to the Escherichia coli Shiga Toxins (Verocytotoxins) and Options for Toxoid Immunization

Japanese Journal of Medical Science and Biology

Volumn 51, Issue , 1998, Pages

  Karmali, Mohamed A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SHIGA TOXIN; VACCINE; VEROTOXIN;

CLINICAL TRIAL; CONFERENCE PAPER; ENTEROBACTER INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; META ANALYSIS; NONHUMAN; WESTERN BLOTTING;

BACTERIAL TOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNIZATION; SHIGA-LIKE TOXIN I; TOXOIDS;

ENTEROBACTER; ESCHERICHIA COLI;

EID: 0032406751     PISSN: 00215112     EISSN: None     Source Type: Journal    
DOI: 10.7883/yoken1952.51.Supplement1_S26     Document Type: Article

References (50)

1. Acheson, D.W.K., M.M. Levine, J.B. Kaper, and G.T. Keusch. (1996): Protective immunity to shiga-like toxin 1 B-subunit-producing Vibrio cholerae CVD 103 HgR. Infect. Immun. 64 : 355.
2. Barrett, T.J., J.H. Green, P.M. Grifnn, A.T. Payia, S.M. Ostroff, and I.K. Wachsmuth. (1991): Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Shiga-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Curr. Microbiol 23: 189-195.
3. Bielasczewska, M., I. Clarke, M.A. Karmali, and M. Petric. (1997): Locahzation or intravenously administered verocytotoxins (shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits. Infect. Immun. 65: 2509-2516.
4. Bitzan, M., K. Ludwig, M. Klemt, H. König, J. Büren, and D.E. Müller Wiefel. (1993): The role or Escherichia coli infections in the classical (enteropathic) haemolytic uraemic syndrome: Results of a Central European, multicentre study. Epidemiol. Infect. 110: 183-196.
5. Calderwood, S., D.W.K. Acheson, G.T. Keusch, T.J. Barrett, P.M. Griffin, N.A. Strockbine, B. Swaminathan, J.B. Kaper, M.M. Levine, B.S. Kaplan, H. Karch, A.D. O'Brien, T.G. Obrig, Y. Takeda, PT. Tarr, and I.K. Wachsmuth. (1996): Proposed New Nomenclature for SLT (VT) Family. ASM News. 62: 118-119.
6. Caprioli, A., I. Luzzi, F. Rosmini, P. Pasquini, R. Cirrincione, A. Gianviti, M. Matteucci, and G. Rizzoni. (1992): Hemolytic-uremic syndrome and vero cytotoxin-producing Escherichia coli infection in Italy. J. Infect. Dis. 166: 154-158.
7. Caprioli, A., I. Luzzi, L. Seganti, M. Miarchetti, M. Karmali, I. Clarke, and B. Boyd. (1994): Frequency and nature of verocytotoxin 2 (VT2) neutralizing activity in human and animal sera, p.353-356. In M. Karmali and A. Goglio (ed.), Recent Advances in Verocytotoxin-producing Escherichia coli infection. ELSEVIER Sciences, Amsterdam.
8. CDC. (1993): Update: Multistate Outbreak of Escherichia coli O157:H7 infections from Hamburgers-Western United States, 1992-1993. J. Amer, Med. Assoc, 269: 2194-2196.
9. Fukushima, H., T. Hashizume, and T. Kitani. (1997): Presented at the 3rd lnternational Symposium and Workshop on Shiga toxin (Verocytotoxin)-producing Escherichia coil infection., Baltimore, MD, June 22-26.
10. Gomez, H.F., H. Ho, S. Shah, E.L. Lopez, and T.G. Cleary. (1994): Mapping epitopic regions of shiga toxin B subunit using milk secretory immunoglobulin A (sIgA), p.345-347. In M. Karmali and A.Goglio (ed.), Recent Advances in Verocytotoxin-producing Escherichia coli infection. ELSEVIER Sciences, Amsterdam.
11. Greatorex, J.S., and G.M. Thorne. (1994): Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolyticuremic syndrome patients and healthy subjects, J. Clin. Microbiol. (32): 1172-1178.
12. Griffin, P.M. (1995): Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli, p.739-761. In M. J. Blaser, P.D. Smith, J.I. Ravdin, H.B. Greenberg, and R.L. Guerran (ed.), Infections of the Gastrointestinal Tract. Raven Press, Ltd, New York.
13. Gunzer, F., and H. Karch. (1993): Expression of A-subunit and B-subunit of shiga-like toxin II as fusions with glutathione S-transferase and their potential for use in seroepidemiology. J. Clin. Microbiol. 31: 2604-.
14. Harari, I., and R. Arnon. (1990): Carboxy-terminal peptides from the B subunit of shiga toxin induce a local and parenteral protective effect. Molecular Immunol. 27: 613-621.
15. Harari, I., A. Donohue-Rolfe, G.T. Keusch, and R. Arnon. (1988): Synthetic peptides or Shiga toxin B subunit induce antibodies which neutralize its biological activity. Infect. Immun. 56: 1618-1624.
16. Head, S.C., M.A. Karmali, M.E. Roscoe, M. Petric, N.A. Strockbine, and I.K. Wachsmuth. (1988): Serological Differences Between Verocytotoxin 2 and Shiga-like Toxin II.: 751.
17. Howard, J.G. (1955): Observations on the intoxication produced in mice and rabbits by the neurotoxin of Shigella shigae. Br. J. Exp. Pathol. 36:439- 446.
18. Jarvis, K.G., and J.B. Kaper. (1996): Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infect. Immun. 64:4826-4829.
19. Kaper, J.B. (1994): Molecular genetics of Attaching and Effacing E. coli p.223-234. In M.A. Karmahand A. Goglio (ed.), Recent Advances in Verocytotoxin-producing Escherichia coli infections. ELSEVIER Science, Amsterdam.
20. Karmali, M.A. (1989): Infection by Verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2:15-38.
21. Karmali, M.A., M. Petric, C. Lim, P.C. Fleming, G.S. Arbus, and H. Lior. (1985): The association between hemolytic uremic syndrome and infection by Verotoxin-producing Escherichia coli. 151:775-782.
22. Karmali, M.A., M. Petric, C. Lim, P.C. Fleming, and B.T. Steele. (1983): Escherichia coli cytotoxin, hemolytic uremic syndrome, and hemorrhagic colitis. Lancet. ii : 1299-1300.
23. Karmali, M.A., M. Petric, M. Winkler, M. Bielasczewska, J. Brunton, N. van de Kar, T. Morooka, G.B. Nair, S.E. Richardson, and G.S. Arbus. (1994): Enzyme-linked immunosorbent assay (ELISA) fbr detection of IgG antibodies to Escherichia coli Verocytotoxin l. J. Clin. Microbiol. 32: 1457-1463.
24. Karmali, M.A., B.T. Steele, M. Petric, and C. Lim. (1983): Sporadic cases of hemolytic uremic syndrome associated with fecal cytotoxin and cytotoxinproducing Escherichia coli. Lancet. i: 619-620.
25. Konowalchuk, J., J.I. Speirs, and S. Stavric. (1977): Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 18: 775-779.
26. Levine, M.M., J. McEwen, G. Losonsky, M. Reymann, I. Harari, J.E. Brown, D.N. Taylor, A. Donohue-Rolfe, D. Cohen, M. Bennish, Y.L. Lim, and R. Arnon. (1992): Antibodies to Shiga holotoxin and to two synthetic peptides ofthe B subunit in sera of patients with Shigella dysenteriae 1 dysentery. J. Clin. Microbiol. 30: 1636-1641.
27. Loirat, C., E. Sonsino, A.V. Moreno, G. Pillion, J.C. Mercier, F. Beaunls, and H. Mathieu. (1984): Hemolytic uremic syndrome: an analysis of the natural history and prognostic features. Acta Pediatr Scand. 73: 505-514.
28. Lopez, E.L., M. Diaz, S. Devoto, S. Grinstein, M. Woloj, B.E. Murray, E. Rubeglio, F. Mendilharzu, M. Turco, M. Vasquez, L. Pickering, and T.G. Cleary. (1991): Evidence of infection with organisms producing shiga-like toxins in household contacts of children with hemolytic uremic syndrome. Pediatr. Inf. Dis. J. (10): 20-24.
29. Lopez, E.L., M. Diaz, S. Grinstein, S. Devoto, F. Mendilaharzu, B.E. Murray, S. Ashkenazi, E. Rubeglio, M. Woloj, M. Vasquez, M. Turco, L.K. Pickering, and T.G. Cleary. (1989): Hemolytic Uremic Syndrome and Diarrheain Argentine Children: The Role of Shiga-like Toxins. J. Infect. Dis. 160: 469-475.
30. Ludwig, K., M.A. Karmali, M. Petric, V. Sarkim, and D.E. Muller-Wiefel. (1997): Presented at the 3rd international Symposium and Workshop on Shiga toxin (Verocytotoxin)-producing Escherichia coli infections, Baltimore, MD, June 22-26.
31. Luzzi, I., C. Farina, A. Goglio, U. Scardellato, P. Pizzocaro, I. Benedetti, F. Minelli, and A. Caprioli. (1994): Seroprevalence of neutralizing antibodies to Escherichia coli verotoxins in the population of two Italian regions, p.85-88. In M. Karmali and A. Goglio (ed.), Recent Advances in Verocytotoxinproducing Escherichia coli infection. ELSEVIER Sciences, Amsterdam.
32. MacLeod, D.L., and C.L. Gyles. (1991): Immunization of pigs with apurified shiga-like toxin II variant toxoid. Vet. Microbiol. 29:309-318.
33. Morooka, T., M. Petric, G.S. Arbus, M. Winkler, and M.A. Karmali. (1994): Distribution of Verocytotoxins (Shiga-like toxins) among clinical isolates of Verocytotoxin-producing Escherichia coli, Medical Bull. Fukuoka Univ. 21: 263-268.
34. Newburg, D.S., S. Ashkenazi, and T.G. Cleary. (1992): Human milk contains the shiga toxin and shiga-like toxin receptor glycolipid Gb3. J. Infect. Dis. 166: 832-835.
35. Novillo, A.A., L.E. Voyer, R. Cravioto, M.C. Freire, G. Castaao, R. Wainstein, and N. Binztein. (1988): Haemolytic uraemic syndrome associated with faecal cytotoxin and verotoxin neutralizing antibodies. Pediatr. Nephrol. 2:288-290.
36. O'Brien, A.D., V.L. Tesh, A. Donohue-Rolfe, M.P. Jackson, S. Olsnes, K. Sandvig, A.A. Lindberg, and G.T. Keusch. (1992): Shiga toxin: Biochemistry, Genetics,Mode of Action. and Role in Pathogenesis. Curr. Topics Microbiol. Immunol. 180: 65-94.
37. Pai, C.H., N. Ahmed, H. Lior, W.M. Johnson, H.V. Sims, and D.E. Woods. (1988): Epidemiology of Sporadic Diarrhea Due to Verocytotoxin-Producing Escherichia coli: A Two-Year Prospective Study. J. Infect. Dis. 157: 1054-1057.
38. Piscione, T.D., M.A. Karmali, D. Stephens, R. Donckerwolke, P.I. Tarr, E. Harvey, and G.S. Arbus. (1997): Presented at the 3rd International Symposium and Workshop on Shiga toxin (Verocytotoxin)-producing Escherichia coli infections, Baltimore, MD, June 22-26.
39. Reymond, D., R.P. Johnson, M.A. Karmali, M. Petric, M. Winkler, S. Johnson, K. Rahn, S. Renwick, J. Wihon, R.C. Clarke, and J. Spika. (1996): Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in heakhy farm family members and urban residents. J. Clin. Microbiol. 34: 2053-2057.
40. Reymond, D., M.A. Karmali, I. Clarke, M. Winkler, and M. Petric. (1997): Comparison of the Western Blot assay with the neutralizing antibody and enzyme-linked immunosorbent assays to measure antibody to verocytotoxin 1. J. Clin. Microbiol. 35: 609-613.
41. Richardson, S.E., T.A. Rotman, V. Jay, C.R. Smith, L.E. Becker, M. Petric, N.F. Olivieri, and M.A. Karmali. (1992): Experimental verocytotoxemia in rabbits. Infect. Immun. 60: 4154-4167.
42. Riley, L.W., R.S. Remis, S.D. Helgerson, H.B. McGee, J.G. Wells, B.R. Davis, R.J. Hebert, E.S. Olcott, L.M. Johnson, N.T. Hargrett, P.A. Blake, and M.L. Cohen. (1983): Hemorrhagic colitis associated with a rare Escherichia coli serotype. New Engl. J. Med. 308: 681-685.
43. Robson, W.L.M., A.K. Leung, and D.J. Miller-Hughes. (1993): Recurrent hemorrhagic cohtis caused by Escherichia coli O157:H7. Pediatr. Infect. Dis. J. 12:699-701.
44. Rowe, P.C., E. Orrbine, G.A. Wells, and P.N. McLaine. (1991): Epidemiology of hemolytic uremic syndrome in Canadian children from 1986 to 1988. J. Pediatr. 119:218-224.
45. Scotland, S.M., B. Said, A. Thomas, and B. Rowe. (1994): Ability of human sera to neutralize the activity of Vero cytotoxins VT1, VT2, and variant forms of VT2. FEMS Microbiol. Letts. 115 :285-289.
46. Siegler, R.L., P.M. Griffin, and T.J. Barrett. (1993): Recurrent hemolytic uremic syndrome secondary to Escherichia coli O157:H7 infection. Pediatrics: 666-668.
47. Smith, J.W.G., and J.G. Collee. (1990): Tetanus, p.331-351. In G.R. Smith and C.S.F. Easman (ed.), Bacterial Diseases, Eighth ed, vol.3. B.C. Decker, Inc., Philadelphia.
48. Takeda, T., H. Nakao, T. Yamanaka, T. Igarashi, Y. Takeda, and N. Kobayashi. (1993): High prevalence of serum antibodies to verotoxin 1 and 2 among healthy adults in Japan. J. Infect. 27:211-212.
49. Thomas, A., H.R. Smith, G.A. Willshaw, and B. Rowe. (1991): Nonradioactively labelled polynucleotide and oligonucleotide DNA probes for selectively detecting Escherichia coli strains producing Verocytotoxins VT1, VT2, and VT2 variant. Molecular and cellular probes. 5:129-135.
50. Trompeter, R.S., R. Schwartz, C. Chantler, M.J. Dillon, G.B. Haycock, R. Kay, and T.M. Barratt. (1983): Haemolytic uraemic syndrome: an analysis of prognostic features. Arch Dis Child. 58:101-105.